In this explorative, population-based study of elderly participants, originally free from prevalent cancers and followed for a median of 9.9 years, we found no increased risk of incident first cancer associated with either fasting or post-OGTT challenge GIP and GLP-1. The gene discussed is GCG; the disease is cancer.